Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modification of Sexual Hormones in Rheumatoid Arthritis Patients by M2000 (β-D-mannuronic Acid) as a Novel NSAID with Immunosuppressive Property.
Jahanbakhshi M, Babaloo Z, Mortazavi-Jahromi SS, Shokri MM, Ahmadi H, Mirshafiey A. Jahanbakhshi M, et al. Among authors: babaloo z. Endocr Metab Immune Disord Drug Targets. 2018;18(5):530-536. doi: 10.2174/1871530318666180418111354. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29667557 Clinical Trial.
Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population.
Hashemi V, Farrokhi AS, Tanomand A, Babaloo Z, Hojjat-Farsangi M, Anvari E, Tahoori MT, Ezzeddini R, Hosseini A, Gharibi T, Ghalamfarsa G, Jadidi-Niaragh F. Hashemi V, et al. Among authors: babaloo z. Immunol Lett. 2018 Dec;204:16-22. doi: 10.1016/j.imlet.2018.10.001. Epub 2018 Oct 4. Immunol Lett. 2018. PMID: 30292536
Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial.
Ahmadi M, Aghdam SA, Nouri M, Babaloo Z, Farzadi L, Ghasemzadeh A, Hamdi K, Movassaghpour AA, Jadidi-Niaragh F, Afkham A, Motallebnezhad M, Eghbal-Fard S, Dolati S, Younesi V, Yousefi M. Ahmadi M, et al. Among authors: babaloo z. Immunol Lett. 2017 Dec;192:12-19. doi: 10.1016/j.imlet.2017.10.003. Epub 2017 Oct 10. Immunol Lett. 2017. PMID: 29030251 Clinical Trial.
Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial.
Ahmadi M, Abdolmohamadi-Vahid S, Ghaebi M, Dolati S, Abbaspour-Aghdam S, Danaii S, Berjis K, Madadi-Javid R, Nouri Z, Siahmansouri H, Babaloo Z, Nouri M, Yousefi M. Ahmadi M, et al. Among authors: babaloo z. Int Immunopharmacol. 2019 Sep;74:105730. doi: 10.1016/j.intimp.2019.105730. Epub 2019 Jul 9. Int Immunopharmacol. 2019. PMID: 31299610 Clinical Trial.
86 results